Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Dems' 'Better Deal' Would Create Drug Price Gouging 'Enforcer'

Jul 25 2017

• By Derrick Gingery

Capitol House

Related Content

Generic Industry Sues To Halt Maryland's 'Price Gouging' Law

Jul 07 2017

The Bully Pulpit: Trump Versus Drug Prices

Jan 18 2017

FDA Drug Pricing Policy Offers Short-Term PR Gain, More Long-Term Actual Benefit

Jun 28 2017

The Clinton Drug Price Board, 23 Years Later

Sep 07 2016

Clinton’s Drug Plan Embraces CER-Driven Pricing ‘Accountability’

Sep 23 2015

Formalizing 'Name And Shame': New Strategy To Rein In Price Increases

Sep 21 2016

Drug Price Control Proposals Pared Down In Democrats’ Draft Platform

Jul 05 2016

EpiPen Price Story Highlights Growing Impact Of Drug Deductibles

Aug 30 2016

Related Companies

Vyera Pharmaceuticals, LLC

Viatris Inc.

Additional Topics

United States Pricing Debate Legislation Policy BioPharmaceutical

More from Pricing Debate

More from Market Access

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window